4.7 Review

Mast Cells in Early Rheumatoid Arthritis

期刊

出版社

MDPI
DOI: 10.3390/ijms20082040

关键词

mast cells; arthritis; synovial membrane

资金

  1. Pathobiology of Early Arthritis Cohort (PEAC), MRC grant [36661]
  2. R4RA (A Randomised, open labeled trial investigating the mechanisms for Response-Resistance to RTX versus TOC in anti-TNFalpha-ir RA patients-EudraCT), NIHR-EME Grant [2012-002535-28, 11/100/76]
  3. STRAP (Stratification of Therapy for RA by Pathobiology-EudraCT), MRC Strategic Grant [2014-003529-16, MR/K015346/1]
  4. NIHR Transitional Research Fellowship
  5. MRC [MR/K015346/1, G0800648] Funding Source: UKRI

向作者/读者索取更多资源

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by inflammation of the synovial membrane, with thickening of the synovial layer, cellular hyperplasia, and infiltration of immune cells. Mast cells (MCs) are cells of the innate immunity present in healthy synovia and part of the cellular hyperplasia characterizing RA synovitis. Although their presence in synovia has been well described, the exact functions and the correlation of MCs with disease development and progression have been debated, particularly because of contradictory data obtained in animal models and from patients with longstanding disease. Here, we present a revision of the literature on MCs in RA, including the most recent observations obtained from patients with early RA, indicating MCs as relevant markers of disease severity in early RA.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据